Medical Devices Philippines

Philippines Liquid Biopsy Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Philippines Liquid Biopsy Market Industry Trends and Forecast to 2034: Segmented by (Biomarker, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Philippines · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $18.2 Mn Placeholder estimate
Estimate 2025 $21.3 Mn 0.2% of the global market
Projected 2034 $88.8 Mn 317.2% Adds $67.5 Mn over 9 forecast years
CAGR 2025–2034 17.2% Faster than 90% of 173 Medical Devices markets here
Key players 6 +1
  • Philippines is 0.24% of the global market.
  • In APAC, the largest is China at $835.5 Mn.
  • Fastest growing: India at 20% a year.
  • Philippines ranks 6th of 10 by size in APAC.

Market size projection

Philippines

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$67.5 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Liquid Biopsy Market market size by year, Philippines
YearMarket sizeChange that yearSince 2025
2024 (estimate) $18.2 Mn — —
2025 (base) $21.3 Mn +$3.1 Mn —
2026 (forecast) $25.0 Mn +$3.7 Mn +17.2%
2027 (forecast) $29.2 Mn +$4.3 Mn +37.4%
2028 (forecast) $34.3 Mn +$5.0 Mn +61%
2029 (forecast) $40.2 Mn +$5.9 Mn +88.7%
2030 (forecast) $47.1 Mn +$6.9 Mn +121.1%
2031 (forecast) $55.2 Mn +$8.1 Mn +159.2%
2032 (forecast) $64.7 Mn +$9.5 Mn +203.7%
2033 (forecast) $75.8 Mn +$11.1 Mn +256%
2034 (forecast) $88.8 Mn +$13.0 Mn +317.2%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $8.90 Bn
  2. North America $4.10 Bn
  3. US $3.88 Bn
  4. APAC $2.00 Bn
  5. Europe $1.60 Bn
  6. China $835.5 Mn
  7. Canada $632.6 Mn
  8. Japan $637.9 Mn
  9. Latin America $360.1 Mn
  10. Middle East $328.0 Mn
  11. Germany $271.7 Mn
  12. UK $252.8 Mn
  13. France $252.9 Mn
  14. Brazil $213.0 Mn
  15. Spain $189.9 Mn
  16. Ecuador $191.0 Mn
  17. Italy $182.5 Mn
  18. Saudi Arabia $170.5 Mn
  19. India $164.7 Mn
  20. Africa $128.9 Mn
  21. Mexico $116.6 Mn
  22. Russia $100.6 Mn
  23. Australia $99.4 Mn
  24. New Zealand $94.9 Mn
  25. South Africa $60.9 Mn
  26. UAE $48.1 Mn
  27. Egypt $23.2 Mn
  28. Philippines (this report) $21.3 Mn
  29. Hong Kong $14.2 Mn
  30. Malaysia $13.2 Mn
  31. Singapore $12.2 Mn
  32. Thailand $11.8 Mn
  33. Kenya $7.0 Mn

Report snapshot

Philippines Liquid Biopsy Market Analysis at a glance
Market size, 2025$21.3 Mn placeholder estimate
Forecast, 2034$88.8 Mn placeholder estimate
Growth (CAGR), 2025–203417.2% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsBiomarker, application and end user (see all)
Key playersGuardant Health, Inc., Roche, GRAIL, Natera, Exact Sciences Corporation and 1 more (see all)
Regulator in the PhilippinesFDA PhilippinesSource: Food and Drug Administration Philippines. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Philippines Liquid Biopsy Market Analysis Executive Summary

Liquid biopsy finds cancer signals such as tumour DNA in a blood sample, to detect cancer, guide treatment and check for relapse.

Key segments of the liquid Biopsy market include biomarker (Circulating Tumor DNA, Circulating Tumor Cells and Exosomes) and application (Treatment Selection, Recurrence Monitoring and Early Detection).

Bar chart: Philippines Liquid Biopsy market size, 2024–2034, placeholder estimates. $18.2 Mn in 2024, $21.3 Mn in 2025 and $88.8 Mn in 2034, 17.2% CAGR.
Philippines Liquid Biopsy market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Philippines Liquid Biopsy Market Dynamics

Market Growth Drivers

Rising cancer cases, earlier detection, precision medicine and a strong pipeline of targeted and immune therapies are driving the liquid Biopsy market. Faster approvals and new combinations are improving survival.

Opportunity

Biomarker-led treatment, earlier lines of therapy and expansion into emerging markets offer strong growth for the liquid Biopsy market.

Market Restraints

High treatment costs, drug resistance, side effects and unequal access to cancer centres hold back the liquid Biopsy market, especially in low- and middle-income countries.

Competitive Landscape for Liquid Biopsy Market in Philippines

The liquid Biopsy market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Liquid Biopsy Market in Philippines

Liquid Biopsy in the Philippines: rules and payment

Medical devices need registration or notification with the Food and Drug Administration of the Philippines (FDA).⁠[1] PhilHealth is the national health insurer, and the Universal Health Care Act of 2019 makes every Filipino a member.⁠[2]

[1] Food and Drug Administration Philippines. Checked 14 Nov 2026.

[2] PhilHealth. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how liquid Biopsy products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Philippines.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Liquid Biopsy right now, from free public sources.

Latest research 10,752 papers since 2021 (worldwide)

  1. Deploying liquid intelligence in cancer: Finding answers in our blood. Cell, 2026
  2. Plasma ATR-FTIR spectroscopy combined with machine learning for early classification of response to neoadjuvant endocrine therapy: exploratory results from the ANNE trial. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2026
  3. APOBEC3-mediated therapy resistance and immunogenicity in solid tumors: from genomic scars to therapeutic vulnerabilities. ESMO open, 2026
  4. A noninvasive risk stratification prediction model for neuroblastoma through integration of multidimensional clinical indicators. European journal of pediatrics, 2026
  5. Recent Advancements in Diagnosis and Targeted Therapy of Pancreatic Cancer. Anti-cancer agents in medicinal chemistry, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Liquid Biopsy in context

The Philippines compared

  • Health spending per person: 194 US$ per person (2023). World: 1,317 US$ per person (2023). 8th highest of the 15 countries we cover in APAC.[1]
  • Doctors: 0.79 per 1,000 people (2021). World: 1.86 per 1,000 people (2022). 9th highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 5.7% of people (2025). World: 10.4% of people (2025). 14th highest of the 16 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Liquid Biopsy market in the Philippines?
Placeholder estimate: about $21.3 Mn in 2025, rising to about $88.8 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Liquid Biopsy market in the Philippines growing?
Placeholder estimate: about 17.2% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Liquid Biopsy market report cover?
The report splits the market by biomarker (Circulating Tumor DNA, Circulating Tumor Cells, Exosomes), application (Treatment Selection, Recurrence Monitoring, Early Detection) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Liquid Biopsy market?
Key players include Guardant Health, Inc., Roche, GRAIL, Natera, Exact Sciences Corporation and Illumina, Inc..
What is driving the Liquid Biopsy market?
Rising cancer cases, earlier detection, precision medicine and a strong pipeline of targeted and immune therapies are driving the liquid Biopsy market. Faster approvals and new combinations are improving survival.
Who regulates Liquid Biopsy in the Philippines?
Medical devices need registration or notification with the Food and Drug Administration of the Philippines (FDA). Source: Food and Drug Administration Philippines. Checked 14 Nov 2026.
How is healthcare paid for in the Philippines?
PhilHealth is the national health insurer, and the Universal Health Care Act of 2019 makes every Filipino a member. Source: PhilHealth. Checked 14 Nov 2026.
How much research is published on Liquid Biopsy?
PubMed lists 10,752 papers on Liquid Biopsy added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Liquid Biopsy in Philippines? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Brain Cancer Diagnosis: Imaging and New BiomarkersAbout 321,000 people were diagnosed with brain and nervous system tumours in 2022, and about 248,000 died… Bioinformatics: Making Sense of Health DataSequencing a human genome fell from about $50 million in 2003 to under $1,500 by late 2015. Bioinformatics… Dermatology Diagnostics: AI and Skin HealthSkin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions…
Back to Catalogue
Keep exploring

Related Medical Devices reports in Philippines

See all
Same topic, other categories

Related on oncology and diagnostics and lab testing

See the topic